Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 Q2- Text added to 2015 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ADC, ASU, BeiGene, beta, Biopharma, BRAVURA, breast, checkpoint, Cluster, colon, Conference, conjugate, deacetylase, deferral, discretion, driven, escalation, explore, FASB, fast, footnote, FRESCO, Germany, guidance, hallmark, HDAC, heighten, histone, immunotherapy, Inaugural, joint, melanoma, mice, monotherapy, mouse, payer, pleiotropic, Principia, receptor, SignalRx, solid, sponsor, traditional, unmet, vendor, vivo, weill
Removed:
collaborate, inflammation, inflammatory, payor, single
Valuein 2015 Q2 filing- Value in 2015 Q3 filing
Original filings
Filing view